Cambridge Trust’s iShares Biotechnology ETF IBB Stock Holding History

Cambridge Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$61.5K	Sell	448 -207	-32%	-$28.3K	﹤0.01%	402
2023 Q4	$89K	Hold	655	–	–	﹤0.01%	353
2023 Q3	$80.1K	Sell	655 -75	-10%	-$9.54K	﹤0.01%	372
2023 Q2	$92.7K	Hold	730	–	–	﹤0.01%	363
2023 Q1	$94.3K	Sell	730 -77	-10%	-$10.1K	﹤0.01%	362
2022 Q4	$106K	Sell	807 -457	-36%	-$59.1K	﹤0.01%	361
2022 Q3	$148K	Sell	1,264 -173	-12%	-$21.5K	0.01%	314
2022 Q2	$169K	Sell	1,437 -55	-4%	-$6.53K	0.01%	319
2022 Q1	$194K	Sell	1,492 -590	-28%	-$76.9K	0.01%	344
2021 Q4	$318K	Sell	2,082 -527	-20%	-$81.6K	0.01%	272
2021 Q3	$422K	Sell	2,609 -88	-3%	-$14.8K	0.02%	189
2021 Q2	$441K	Buy	2,697 +179	+7%	+$27.6K	0.02%	187
2021 Q1	$379K	Sell	2,518 -1,001	-28%	-$159K	0.02%	201
2020 Q4	$533K	Sell	3,519 -2,566	-42%	-$367K	0.03%	151
2020 Q3	$824K	Sell	6,085 -941	-13%	-$128K	0.04%	124
2020 Q2	$968K	Sell	7,026 -1,942	-22%	-$248K	0.05%	123
2020 Q1	$966K	Sell	8,968 -3,451	-28%	-$397K	0.07%	118
2019 Q4	$1.5M	Sell	12,419 -1,675	-12%	-$187K	0.08%	114
2019 Q3	$1.4M	Sell	14,094 -118,023	-89%	-$12.4M	0.08%	116
2019 Q2	$14.4M	Sell	132,117 -643	-0.5%	-$68.4K	0.84%	46
2019 Q1	$14.8M	Buy	132,760 +879	+0.7%	+$96.4K	0.89%	43
2018 Q4	$12.7M	Sell	131,881 -2,579	-2%	-$274K	0.88%	40
2018 Q3	$16.4M	Buy	134,460 +1,069	+0.8%	+$126K	0.95%	41
2018 Q2	$14.6M	Sell	133,391 -1,226	-0.9%	-$131K	0.91%	42
2018 Q1	$14.4M	Buy	134,617 +537	+0.4%	+$59.5K	0.92%	40
2017 Q4	$14.3M	Sell	134,080 -68	-0.1%	-$7.27K	0.9%	40
2017 Q3	$14.9M	Buy	134,148 +393	+0.3%	+$42K	1%	39
2017 Q2	$13.8M	Sell	133,755 -4,572	-3%	-$450K	0.95%	39
2017 Q1	$13.5M	Sell	138,327 -492	-0.4%	-$47.1K	0.9%	41
2016 Q4	$12.3M	Sell	138,819 -498	-0.4%	-$45.3K	0.86%	42
2016 Q3	$13.4M	Buy	139,317 +720	+0.5%	+$68.5K	0.98%	39
2016 Q2	$11.9M	Buy	138,597 +7,701	+6%	+$691K	0.91%	44
2016 Q1	$11.4M	Sell	130,896 -48,546	-27%	-$4.34M	0.93%	44
2015 Q4	$20.2M	Sell	179,442 -492	-0.3%	-$53.4K	1.66%	16
2015 Q3	$18.2M	Sell	179,934 -15,675	-8%	-$1.88M	1.59%	20
2015 Q2	$24.1M	Sell	195,609 -738	-0.4%	-$88.3K	1.99%	12
2015 Q1	$22.5M	Buy	196,347 +504	+0.3%	+$55.6K	1.89%	13
2014 Q4	$19.8M	Sell	195,843 -903	-0.5%	-$87.8K	1.72%	17
2014 Q3	$17.9M	Buy	196,746 +1,179	+0.6%	+$103K	1.59%	21
2014 Q2	$16.8M	Buy	195,567 +36,582	+23%	+$2.88M	1.45%	23
2014 Q1	$12.5M	Sell	158,985 -1,542	-1%	-$128K	1.15%	39
2013 Q4	$12.2M	Buy	160,527 +70,743	+79%	+$5.02M	1.13%	37
2013 Q3	$6.27M	Buy	+89,784	New	+$5.88M	0.62%	55

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Cambridge Trust's IBB Position: Q1 2024 in Review

Cambridge Trust reduced its iShares Biotechnology ETF (IBB) stake by 32% in Q1 2024, selling an estimated $28.3K and leaving 448 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Cambridge Trust first reported a position in IBB in Q3 2013 and has held it in 43 quarters since. The position peaked at $24.1M in Q2 2015. 901 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Cambridge Trust held 448 shares of iShares Biotechnology ETF worth $61.5K as of Q1 2024.
Cambridge Trust sold 207 iShares Biotechnology ETF shares in Q1 2024, an estimated $28.3K.
iShares Biotechnology ETF made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #402 holding.
Cambridge Trust first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 43 quarters since.
Cambridge Trust's iShares Biotechnology ETF position peaked at $24.1M in Q2 2015.
901 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.